drugset
drugset / Trial / NCT02132390

Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

NCT02132390 ↗

Phase 3 Unknown 300 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Compare the potential benefits of adjuvant toremifene with or without goserelin in premenopausal women with stage I-IIIA, hormonal receptor positive breast cancer accompanied with or without chemotherapy induced amenorrhoea.

Timeline

Start
2014-05
Primary completion
2024-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified — —
Subject Toremifene Small molecule — Oral

Indications

breast cancer chemotherapy-induced toxicity